PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+42.91%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
(+31%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
9.69%
Top 10 Holdings %
Top 10 Hldgs %
99.16%
Holding
12
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Vaxcyte
PCVX
|
$19.3M |
| 2 |
Trevi Therapeutics
TRVI
|
$6.27M |
| 3 |
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
|
$411K |
Top Sells
| 1 |
Bolt Biotherapeutics
BOLT
|
$10.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Oculis Holding
OCS
$844M
| $44.7M | 27.68% |
2,300,774
| – | – |
|
|
2
Vaxcyte
PCVX
$4B
| $42.4M | 26.3% |
1,305,125
+594,391
| +84% | +$19.3M |
|
3
Arcutis Biotherapeutics
ARQT
$1.86B
| $29.7M | 18.43% |
2,120,508
| – | – |
|
|
INZY
4
DELISTED
Inozyme Pharma
INZY
| $18M | 11.14% |
4,494,851
| – | – |
|
|
ZBIO
5
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $7.55M | 4.68% |
779,045
+42,400
| +6% | +$411K |
|
|
6
Trevi Therapeutics
TRVI
$883M
| $6.27M | 3.89% |
+1,146,110
| New | +$6.27M |
|
|
VIGL
7
DELISTED
Vigil Neuroscience
VIGL
| $4.46M | 2.76% |
560,595
| – | – |
|
8
Recursion Pharmaceuticals
RXRX
$2.04B
| $3.01M | 1.87% |
595,518
| – | – |
|
|
BIOA
9
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $2.7M | 1.67% |
653,374
| – | – |
|
10
IO Biotech
IOBT
$104M
| $1.2M | 0.74% |
864,197
| – | – |
|
11
Rallybio
RLYB
$22.4M
| $813K | 0.5% |
2,404,644
| – | – |
|
|
12
Bolt Biotherapeutics
BOLT
$9.85M
| $546K | 0.34% |
94,573
-1,796,894
| -95% | -$10.4M |
|